Published in Hum Reprod on February 21, 2012
Fertility preservation for non-medical reasons: controversial, but increasingly common. Dtsch Arztebl Int (2015) 2.10
Oocyte vitrification: advances, progress and future goals. J Assist Reprod Genet (2014) 0.98
Optimal timing for elective egg freezing. Fertil Steril (2015) 0.84
Oocyte cryopreservation beyond cancer: tools for ethical reflection. J Assist Reprod Genet (2015) 0.75
The Human Oocyte Preservation Experience (HOPE) Registry: evaluation of cryopreservation techniques and oocyte source on outcomes. Reprod Biol Endocrinol (2017) 0.75
Is employer coverage of elective egg freezing coercive?: a survey of medical students' knowledge, intentions, and attitudes towards elective egg freezing and employer coverage. J Assist Reprod Genet (2017) 0.75
Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation. J Assist Reprod Genet (2017) 0.75
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08
Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet (1992) 7.59
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod (2011) 5.49
High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod (1993) 5.06
Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update (2007) 3.96
Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update (2001) 3.35
Fertility and ageing. Hum Reprod Update (2005) 2.68
Intracytoplasmic single sperm injection of 1-day-old unfertilized human oocytes. Hum Reprod (1993) 2.46
The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reprod Biomed Online (2011) 2.38
Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis. Hum Reprod (2009) 2.26
GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update (2005) 2.12
Transvaginal removal of gallbladders with large stones after laparoscopic cholecystectomy. Surg Laparosc Endosc (1993) 2.07
Pentoxifylline is not useful in enhancing sperm function in cases with previous in vitro fertilization failure. Fertil Steril (1993) 2.04
Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles. Hum Reprod (1993) 2.02
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod (2005) 2.02
Cytogenetics of infertile men. Hum Reprod (1996) 2.00
Economic evaluation of the administration of follitropin-beta with a pen device. Reprod Biomed Online (2005) 1.99
Post-neonatal health and development of children born after assisted reproduction: a systematic review of controlled studies. Eur J Obstet Gynecol Reprod Biol (2006) 1.92
Distribution of spermatogenesis in the testicles of azoospermic men: the presence or absence of spermatids in the testes of men with germinal failure. Hum Reprod (1997) 1.89
Sperm characteristics and outcome of human assisted fertilization by subzonal insemination and intracytoplasmic sperm injection. Fertil Steril (1993) 1.88
Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril (1996) 1.83
Correlation between testicular histology and outcome after intracytoplasmic sperm injection using testicular spermatozoa. Hum Reprod (1996) 1.82
Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum Reprod (2009) 1.78
Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update (2006) 1.76
I. The moral status of the pre-implantation embryo. Hum Reprod (2001) 1.73
Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int J Cancer (2000) 1.70
Absolute asthenozoospermia and ICSI: what are the options? Hum Reprod Update (2011) 1.70
Normal pregnancies resulting from testicular sperm extraction and intracytoplasmic sperm injection for azoospermia due to maturation arrest. Fertil Steril (1996) 1.68
Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update (2005) 1.66
Developmental outcome at 2 years of age for children born after ICSI compared with children born after IVF. Hum Reprod (2003) 1.62
The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod (1995) 1.62
Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins. Hum Reprod (1986) 1.60
Can biological or clinical parameters predict testicular sperm recovery in 47,XXY Klinefelter's syndrome patients? Hum Reprod (2004) 1.59
ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology. Hum Reprod (2008) 1.59
The evolution and outcome of pregnancies from oocyte donation. Hum Reprod (1994) 1.58
Using ejaculated, fresh, and frozen-thawed epididymal and testicular spermatozoa gives rise to comparable results after intracytoplasmic sperm injection. Fertil Steril (1995) 1.56
Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet (2001) 1.54
Taskforce 8: ethics of medically assisted fertility treatment for HIV positive men and women. Hum Reprod (2004) 1.53
Laparoscopic nerve-sparing radical hysterectomy: description of the technique and patients' outcome. Gynecol Oncol (2010) 1.53
Heterotopic pregnancy in a spontaneous cycle: do not forget about it! Eur J Obstet Gynecol Reprod Biol (1999) 1.49
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Hum Reprod (2008) 1.49
Mild ovarian stimulation for IVF. Hum Reprod Update (2008) 1.48
Are there any predictive factors for successful testicular sperm recovery in azoospermic patients? Hum Reprod (1997) 1.48
Effects of pentoxifylline on in-vitro development of preimplantation mouse embryos. Hum Reprod (1993) 1.48
No impact of cryopreservation and thawing on embryo developmental potential--one more example for the problems of retrospective, non-controlled data. Hum Reprod (1998) 1.47
Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. Hum Reprod (2011) 1.46
Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use. Hum Reprod (2010) 1.45
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod (1999) 1.45
Atypical ductus venosus blood flow pattern in fetuses with severe tricuspid valve regurgitation. Ultrasound Obstet Gynecol (2005) 1.44
Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod (2005) 1.44
Comparison of the aneuploidy frequency in embryos derived from testicular sperm extraction in obstructive and non-obstructive azoospermic men. Hum Reprod (2004) 1.43
Tubal transfer: a forgotten ART? Is there still an important role for tubal transfer procedures? Hum Reprod (1996) 1.42
Ultrasound-guided embryo transfer does not offer any benefit in clinical outcome: a randomized controlled trial. Hum Reprod (2007) 1.42
Single embryo transfer in preimplantation genetic diagnosis cycles for women <36 years does not reduce delivery rate. Hum Reprod (2007) 1.42
High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod (1999) 1.41
Conventional in-vitro fertilization versus intracytoplasmic sperm injection for patients requiring microsurgical sperm aspiration. Hum Reprod (1994) 1.41
Umbilical cord diameter at 11-14 weeks of gestation: relationship to nuchal translucency, ductus venous blood flow and chromosomal defects. Fetal Diagn Ther (2006) 1.41
A randomized comparison of the cryopreservation of one-cell human embryos with a slow controlled-rate cooling procedure or a rapid cooling procedure by direct plunging into liquid nitrogen. Hum Reprod (1997) 1.40
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update (2007) 1.39
[Prevention of complications in twin gestations and pregnancies after assisted reproduction]. Z Geburtshilfe Neonatol (2010) 1.39
Auto-controlled study on in-vitro fertilization performance with 'antibody-free' spermatozoa selected by immunobead adsorption from semen of patients with anti-sperm antibodies. Hum Reprod (1994) 1.38
Debate. Assisted reproductive techniques - are we avoiding the genetic issues? Hum Reprod (1996) 1.38
Should requests for donor insemination on social grounds be expanded to transsexuals? Reprod Biomed Online (2003) 1.38
GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online (2006) 1.37
High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy. Hum Reprod (1995) 1.33
GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update (2006) 1.32
Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles. Hum Reprod (1995) 1.31
The relationship between embryo quality and the occurrence of multiple pregnancies. Fertil Steril (1992) 1.30
Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. Hum Reprod (2008) 1.30
The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility. Hum Reprod (1995) 1.27
Which is the best sperm retrieval technique for non-obstructive azoospermia? A systematic review. Hum Reprod Update (2007) 1.26
Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod (2006) 1.26
Cross border reproductive care in six European countries. Hum Reprod (2010) 1.25
The role of the endometrium and embryo in human implantation. Hum Reprod Update (2007) 1.24
Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update (2009) 1.23
An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update (2007) 1.22
Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril (1997) 1.22